Washington, D.C. · Nonprofit
GO2 For Lung Cancer
GO2 For Lung Cancer (Washington, D.C.) receives grants from 102 organizations whose IRS filings report $14,433,550 to it, the largest being The Skip Viragh Foundation Inc ($9,000,000). 56 of them have funded it in more than one year.
- Revenue FY2025
- $12M
- Funders on record
- 102
- Grants received
- $14M
- Net assets
- $11M
What GO2 For Lung Cancer does
Mission
GO2 for Lung Cancer (GO2) relentlessly confronts lung cancer on every front, every day, for everyone. Formed in 2019 through the merger of the Bonnie J. Addario Lung Cancer Foundaton (ALCF) and Lung Cancer Alliance (LCA), (Continued in Schedule O)GO2 is dedicated to increasing survival rates for those at risk, diagnosed, and living with lung cancer. As a nonprofit organization, GO2 is exempt from federal income taxes under Section 501(c)(3) of the Internal Revenue Code (IRC).
As stated on its FY2025 Form 990.
Programs
Excellence in Healthcare Delivery - Expand access to excellence in screening, care, treatment, and survivorship to ensure that our community benefits from life-saving services closer to home.
$2,400,577 spentof which $80,993 as grants$5,560 earned by the program24% of program spendingMarketing - Marketing and communication activities are focused on creating top-of-mind awareness of the organization. We want people to think of GO2 whenever they hear the words "lung cancer," whether patient, caregiver, family, or friend. GO2 is the "go-to" for anyone impacted by the disease for free information, education, and support.
$2,242,627 spent$1,433 earned by the program23% of program spendingResearch - Advance world-class patient-centered clinical, community-engaged, and academic research to inform our understanding of the etiology of lung cancer and to improve quality in the areas of prevention, screening, and care across the continuum.
$1,962,080 spentof which $387,154 as grants$148,428 earned by the program20% of program spendingAdvocacy and Policy - Drive impactful policy efforts and engage in direct advocacy action to secure historic increases in federal research funding, accelerate new treatment approvals, and expand access to high-quality care. Empower millions to become effective self-advocates to improve survivorship outcomes.
$1,471,235 spent$67,750 earned by the program15% of program spendingPatient Support - Deliver life-changing information, education, and support services to the 16 million individuals at risk for or living with lung cancer.
$1,817,360 spent$29,719 earned by the program18% of program spendingFiscal sponsorship - GO2 is Deadliest Cancer Coalition's (DCC) fiscal sponsor.
$61,001 spent1% of program spending
The 6 programs described on its FY2025 Form 990, listed largest first by expense. Program spending in total: $9,954,880.
The organization over time
Each line starts at 100 in 2017, so what you read is the shape rather than the size: 150 means half as much again as 2017, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.
Balance sheet
Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2021 to 2022, from $16M to $22M (+36%).
How it's funded, over time
Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.
98% of GO2 For Lung Cancer’s revenue is contributions — more reliant on donations than three-quarters of its peers (7% for the typical peer).
Surplus & reserves
Operating surplus or deficit each year, and months of liquidity in hand. 5 of the last 8 reported years ran a deficit.
reserve
Leadership and staff
The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.
Chief executive
Laurie Ambrose
President & CEO
Board chair
Adrienne Halper
Chairperson
As listed on its FY2025 Form 990.
Who funds it, year by year
2017 → 2023: the base broadened from 14 funders to 32 funders, grant income rose $307k → $894k.
19 of 102 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 25% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.
From the IRS filings of GO2 For Lung Cancer’s funders (the co-funder graph). Top 30 of 102 funders by total. Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How concentrated its funding is
GO2 For Lung Cancer leans on a few funders — its largest provides 62% of grant income and the top three 76%; half comes from just 1 funder.
the vertical line marks half of all grant income — 1 funder to its left
26% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund GO2 For Lung Cancer.
Largest funder’s share by year: 2017 45% · 2018 44% · 2019 42% · 2020 80% · 2021 82% · 2022 85% · 2023 28% — diversifying over time.
“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How long its funders stay
40% of GO2 For Lung Cancer's funders are still giving 3 years after their first grant; 55% give in more than one year at all.
Share of funders still giving k years after their first recorded grant, pooled across every acquisition cohort. A funder counts as retained in a year only if it made a grant that year. Measured to FY2023, the last fiscal year that has finished arriving — a funder cannot be counted as lapsed in a year most filers have not reached.
Where its funders are
GO2 For Lung Cancer draws 100% of its grant income from funders outside Washington, D.C., across 22 states in all.
In-state vs out-of-state, by year
Funder states come from each funder’s own filing. $3.7M arriving through sponsors registered in 15 states is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Against its field
GO2 For Lung Cancer holds deeper cash reserves than three-quarters of the 2,969 health nonprofits its size.
this organization peer median middle 50% of peers· 2,969 health nonprofits $10M–$100M, FY2025
Organizations like GO2 For Lung Cancer
Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.
In Washington, D.C.
Nationally
Read directly from this organization’s own Form 990, as neutral context.
Where the money goes
78% of spending goes to programs.
Governance
Public support
65%
Share of support from the public (Schedule A) — the basis for its public-charity status.
Footprint & structure
Files a return copy in 2 states
Screen this organization
A dated, signed PDF of the compliance screen for GO2 For Lung Cancer: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.
Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf
Questions and answers
- Who funds GO2 For Lung Cancer?
- GO2 For Lung Cancer (Washington, D.C.) receives grants from 102 organizations whose IRS filings report $14,433,550 to it, the largest being The Skip Viragh Foundation Inc ($9,000,000). 56 of them have funded it in more than one year.
- How many funders does GO2 For Lung Cancer have?
- IRS filings report 102 organizations giving $14,433,550 in grants to GO2 For Lung Cancer, 56 of which have funded it in more than one year.
- Who is the largest funder of GO2 For Lung Cancer?
- The Skip Viragh Foundation Inc is the largest funder on record, with $9,000,000 in grants. The full list of funders is on this page.
- How can an organization like GO2 For Lung Cancer find more funders?
- Start with the funders already giving here, then look at the foundations that back similar organizations in Washington, D.C.. The funding by cause and by state pages list the largest funders for a given area and how to approach them.
These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2025 (financials across 2017–2025), and the filings of 102 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 22, 2026. What this page cannot tell you · view filing